Hardcover, x + 294 pages, NOT ex-library. Interior is very good: clean and bright throughout, with unmarked text, free of inscriptions and stamps, firmly bound. Gently shelfworn boards show two tiny closed edge-nicks (upper corner of the front panel), creases to the lower spine. Issued without a dust jacket.

Seller Inventory # 009400

Contact seller

Report this item

Bibliographic Details

Title: Benefit-Risk Appraisal of Medicines: A Systematic Approach to Decision-Making
Publisher: Wiley-Blackwell
Publication Date: 2009
Language: English
ISBN 10: 0470060859
ISBN 13: 9780470060858
Binding: Hardcover
Edition: 1st Edition
Condition: Good+

About this title

Synopsis

Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available.

The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development. This model utilises a multi-criteria decision analysis which involves selecting, scoring and weighting key benefit and risk attributes and leads to an overall appraisal of benefits and risks of medicines.

Benefit-Risk Appraisal of Medicines establishes the background and criteria required to assess benefit and risk in general and reviews the current practices by regulatory authorities and the pharmaceutical industry, including those models currently available. It outlines the development and evaluation of the authors’ new model and analyses the implications of its implementation.

Describes an innovative, systematic model which leads to transparent and responsible benefit-risk decision making
Contributes important ideas to the debate on benefit-risk appraisal
Provides a future framework for benefit-risk appraisal of medicines

Benefit-Risk Appraisal of Medicines covers the entire process from the discovery of new medicines to their marketing and is ideal for all those who work in the pharmaceutical industry and regulatory authorities,, as well as post-graduate students of pharmaceutical medicine and clinical pharmacology.

About the Author

Dr Sam Salek, Reader in Pharmacoepidemiology, Director - WSP Centre for Socioeconomic Research; Director - Postgraduate Course in Pharmaceutical Medicine, Cardiff University, UK.

Mr Filip Mussen, Johnson & Johnson Pharmaceuticals Research and Development, Belgium.

Prof Stuart Walker, President and Founder, International Institute for Regulatory Science, UK.

"About this title" may belong to another edition of this title.

Store Description

All U.S.-bound orders are now shipped with UPS for reliable delivery. Additional customs or import fees are highly unlikely; however, please note buyers remain responsible for any duties or taxes that U.S. Customs may assess. -- Killarneybooks is a family-run bookshop based in the Republic of Ireland. We take pride in accurate listings, careful packaging, and prompt service - most orders ship within 24 hours. All books listed are in stock and ready for immediate dispatch - we are not dropshippers. Inquiries always welcome.

Visit Seller's Storefront

Seller's business information

killarneybooks
Ireland

Sale & Shipping Terms

Terms of Sale

Shipping Terms

TNT / FedEX express available on request. Please contact us for more details. Thank you.

Shipping rates from Ireland to U.S.A.

Shipping rates from Ireland to U.S.A.
Order quantity	6 to 7 business days	3 to 4 business days
First item	US$ 39.15	US$ 44.15

Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.